The Study of Release of Chlorhexidine from Preparations with Modified Thermosensitive Poly-N-isopropylacrylamide Microspheres by Musial, Witold et al.
The Scientiﬁc World Journal
Volume 2012, Article ID 243707, 8 pages
doi:10.1100/2012/243707 The  cientiﬁcWorldJOURNAL
Research Article
The Study of Release of Chlorhexidine from
Preparations with Modiﬁed Thermosensitive
Poly-N-isopropylacrylamideMicrospheres
Witold Musial,1,2 BojanaVoncina,2 JanuszPluta,1 andVanjaKokol2
1Chair and Department of Pharmaceutical Technology, Wroclaw Medical University, ul. Szewska 38, 50-139 Wrocław, Poland
2Department of Textile Materials and Design, University of Maribor, Smetanova ul. 17, 2000 Maribor, Slovenia
Correspondence should be addressed to Witold Musial, witold.musial@gmail.com
Received 11 October 2011; Accepted 20 November 2011
Academic Editor: Doron J. Aframian
Copyright © 2012 Witold Musial et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The aim of this study was to investigate and compare the release rates of chlorhexidine (CX) base entrapped in the polymeric
beads of modiﬁed poly-N-isopropylacrylamides (pNIPAMs) at temperatures below and over the volume phase transition
temperature (VPTT) of synthesized polymers: pNIPAM-A with terminal anionic groups resulting from potassium persulfate
initiator, pNIPAM-B with cationic amidine terminal groups, and pNIPAM-C comprising anionic terminals, but with increased
hydrophobicity maintained by the N-tert-butyl functional groups. The preparations, assessed in vitro below the VPTT, release an
initialburstofCXatdiﬀerenttimeperiodsbetween120and240min,followedbyaperiodof24h,whentherateofreleaseremains
approximately constant, approaching the zero-order kinetics; the release rates for the polymers beads are as follows: pNIPAM-
C>pNIPAM-B>pNIPAM-A. The pattern of release rates at temperature over the VPTT is as follows: pNIPAM-C>pNIPAM-
A>pNIPAM-B. In the presence of pNIPAM-C, the duration between the start of the release and the attained minimal inhibitory
concentration(MIC)formostofthemicrobes,inconditionsovertheVPTT,increasedfrom60to90min.Thereleaseprolongation
could be ascribed to some interactions between the practically insoluble CX particle and the hydrophobic functional groups of the
polymer.
1.Introduction
Chlorhexidine (CX), the known and widely applied antimi-
crobial agent, still is identiﬁed as the so-called “gold
standard” in many applications, including oral and skin
health applications, as well as some other skin and mucosal
applications [1]. Researchers are evaluating numerous sys-
tems for controlled delivery of CX to the place of the
interest, that is, mucosa of oral cavity, or skin surface. Yue
et al. prepared, by single emulsion, solvent evaporation
technique microparticles of poly(dL-lactic-co-glycolic acid)
containing CX-free base, CX digluconate, and their asso-
ciation or inclusion complex with methylated-beta-cyclo-
dextrin and hydroxypropyl-beta-cyclodextrin [2]. Some
authorsproposedurethanedimethacrylate-triethyleneglycol
dimethacrylate resin system with some success [3]. Early
works included carriers based on acrylic strip [4] and chip of
cross-linked collagen [5]. Also natural polymers as xanthan
[6] or silk ﬁbroin/gelatin hybrid ﬁlms [7]w e r ee v a l u a t e df o r
loading CX.
The approach to eﬀectively use microspheres for CX
delivery to the place of proper activity was evaluated orig-
inally by Egbaria and Friedman [8], who evaluated the
antibacterial activity of human albumin microspheres con-
taining CX dihydrochloride against bacteria of urinary tract.
Themicrospherescomposedofchitosanweresoonevaluated
for preparation of buccal tablets with CX, acting on the oral
mucosa [9]. Wu and Lee [10] applied in theirs microspheres
loaded by chlorhexidin modiﬁed, that is, acetylated and suc-
cinoylated inulin-obtained microspheres were characterized
by prolonged release of CX.
Poly-N-isopropylacrylamides (pNIPAM) are among the
group of most applied macromolecules, characterized by
reversible volume-phase transition at ca. 31◦C[ 11]. The2 The Scientiﬁc World Journal
thermosensitive microgel particles may be applied in many
medical devices, including drug forms for topical use [12,
13]. With the collapse and expansion of the macromolecule
in the aqueous environment, the molecules of the biologi-
cally active substance may be released in a controlled manner
[14, 15]. The deswelling process is controlled by diﬀusion,
where the rate of the collapsing of the macromolecule is
correlated to the dimensions of the pores in the polymeric
matrix [16]. When the VPTT is crossed, the phase transition
from one side enables the expelling of the drug from
the polymeric environment, but on the other hand the
aggregation may be expected, when the microspheres will
adhere to the mucosa surface in the oral cavity.
In our previous studies, we investigated release of CX
from ionic and nonionic polymer hydrogels, namely, from
methylcellulose and modiﬁed polyacrylic acid [17]. Some
approach was made to evaluate the amounts of CX released
from modiﬁed poly-N-isopropylacrylamide by the conduc-
tometry method [18]. The aim of the present work is to
evaluatetheinﬂuenceofthreediﬀerentmicrospheresbatches
on the release of CX in the conditions below and over the
VPTT, applying pharmacopoeia release device.
The pNIPAM microgels, namely, pNIPAM-A, pNIPAM-
B,andpNIPAM-C,withdiﬀerentterminalfunctionalgroups
based on diﬀerent initiators used in surfactant-free disper-
sion polymerization (SFDP), were synthesized in previous
research [19]. For microgels pNIPAM-A and pNIPAM-C,
potassium persulfate was used as an initiator in SFDP, while
forpNIPAM-B,2,2 -azo-bis(2-methylpropionamidine)dihy-
drochloride was used. The microgel pNIPAM-C was syn-
thesized with the addition of comonomer, N-tert-butyl
acrylamide, to increase the hydrophobicity of the received
particles due to the experiments performed by Lynch et al.
[20] as well as Lindmann et al. [21]. The IR spectra of the
freeze-dried polymers obtained from SFEP were compared
with that of the pure components to establish the occurrence
ofpolymerization,andsomephysicalassessmentslikeoptical
microscopy, scanning electron microscopy, VPTT, conduc-
tivity, and pH were carried out to evaluate the products.
The acquired release rates and concentrations of CX released
from CX-loaded pNIPAM microgels were compared with
that obtained from a water dispersion of CX as well as CX-
loadedmethylcellulose(MC)andpolyacrylicacid(PA)beads
[17].
2.MaterialsandMethods
N-isopropylacrylamide 97% (Aldrich), N-tert-butyl acryl-
amide 99% (Acros Organics), N,N -methylenebisacrylam-
ide 99% (Aldrich), potassium persulfate 98% (BDH Lab-
oratory Suppliers (GPR), and 2,2 -azo-bis(2-methylpro-
pionamidine) dihydrochloride 97% (Aldrich) were received
from commercial and industrial suppliers and used with-
out further puriﬁcation. Dialysis bag of molecular weight
cutoﬀ (MWCO) of 12000–14000Da was purchased from
Visking Medicell International Ltd. Deionized water from
the TKA DI 6000 system (Germany) was applied in all the
procedures.
2.1. Synthesis of the Microgels. The N-isopropylacrylamide
derivative microgel particles were synthesized by SFDP in
deionized water at 70◦C, under an inert nitrogen atmo-
sphere due to the procedure reported in former paper
[18]. The pNIPAM-A was characterized as a polymer with
terminal anionic function groups. The pNIPAM-B was
synthesized in the presence of 2,2 -azo-bis(2-methylpro-
pionamidine)dihydrochloride, which resulted in cationic
amidine terminal functional groups. The pNIPAM-C was
characterized as the polymer with anionic terminal func-
tional groups, but with increased hydrophobicity according
to the functional groups introduced during the synthesis.
For better evaluation of the polymerization process, the IR
spectra assessments were performed to exclude the presence
of vinyl groups in the products of the reaction, as well as
to conﬁrm the implementation of respective comonomer
[18]. Also the other basic data on the characteristics of the
microspheres were presented in the previous study, as the
VPTT and scanning electron microscopy images of entities
obtained through the synthesis.
2.2. Preparations of Microspheres-CX Mixtures. The CX-
loaded preparations were developed using the polymers
pNIPAM-A, pNIPAM-B, pNIPAM-C, and for comparison
also MC and PA. The samples were allowed to swell in the
0.5% dispersions of CX for 48h in a water bath at 298K,
under continuous stirring. After 48h, when the incorpora-
tion procedure terminated, the samples were immediately
frozen using liquid nitrogen and freeze-dried by MINI
LYOTRAP LF/LYO/02/1 with vacuum pump model RV5, in
high vacuum mode, at 50% power setting, with vacuum
values in the range of 1 × 10−1–1 × 100mbar (i.e., 1 ×
101–1 × 102 Pa) for 24h, and ﬁnally dispersed in water.
The time for complete incorporation was demonstrated by
previous consequent spectrophotometric assessments of the
ﬁltered samples, which came from the preparations loaded
by chlorhexidine in various, increasing time periods. The
exponential curve ranged the limit, and the amount of
assessed drug did not decrease further after ca. 36 hrs.
To receive the full load, the margin of 12hrs was added.
Composition of the obtained microgel preparations of CX
is given in the attached Table 1.
2.3. Morphology of the Obtained Complexes of Polymer
and CX. The surface and morphology of the freeze-dried
samples were examined using light microscopy (LM). The
morphology of the loaded samples was assessed by the
optical microscope, Olympus BX51, with oculars 20 ×
0.46mm and 50 × 0.80mm, and recorded using a digital
camera, Olympus DP12, U-TVO.5XC-2, by applying direct
day light. To obtain more data about the surface of the
dry samples, the scanning electron microscope (SEM) was
applied, using the FEI QUANTA 200 3D.
2.4. Release Rates. The in vitro release of CX from the
solution in water and from the hydrogel preparations across
artiﬁcial membrane was examined using United States
Pharmacopoeia paddle method with the acceptor volume ofThe Scientiﬁc World Journal 3
Table 1: Composition of investigated preparations.
Components preparation CX (mg) pNIPAM-A (mg) pNIPAM-B (mg) pNIPAM-C (mg) MC (mg) PA (mg) Water (g)
pNIPAM-A-CX 45 90 — — — — 20
pNIPAM-B-CX 45 — 90 — — — 20
pNIPAM-C-CX 45 — — 90 — — 20
MC-CX 45 — — — 90 — 20
PA-CX 45 — — — — 90 20
H2O-CX 45 — — — — — 20
pNIPAM-A-CX, pNIPAM-B-CX, pNIPAM-C-CX: preparations of respective polymers detailed in the text with chlorhexidine, MC-CX: preparation of
methylcellulose and chlorhexidine, PA-CX: preparation of polyacrylic acid and chlorhexidine, and H2O-CX: aqueous dispersion of chlorhexidine.
900mL and a deﬁned diﬀusional area of 64cm2.W a t e rw a s
used as the acceptor phase, and it was adjusted to a pH of 5.5
by the addition of small quantities of 0.1MHCl, to maintain
the pH close to the physiological pH of the skin surface.
After preparation, all the samples, that is, CX dispersion
and loaded hydrogels, were placed in a thermostated water
bath, at 22 and 37◦C for 24h. About 20mL of the sample,
either of the solution of CX or a hydrogel containing the
drug,wasplacedinthedonorcompartment.Sixexperiments
were conducted using these systems for a 24h period. About
1mL of receptor phase was taken as a sample and replaced
with fresh prethermostated acceptor phase. The vessels were
silanized using dichlorodimethyl silane to minimize CX
adsorptionontheglass.Thesamplesweretakenevery10min
for the ﬁrst 100min, then, every 30min for the next 2h, and,
subsequently, every 1h for up to 12h, to achieve 20 mea-
surement points for this time period. The CX in the eluent
was assessed using the UV spectrophotometric method. The
percentage extinction coeﬃcient (a1%,1cm) in 0.01mol/L
HCl solution was 224.12 (P>0.999) at 250nm, and the
method gave a linear response over a concentration range
of 1–20µg/mL [22]. The UV spectrophotometer, TECAN
Inﬁnite 200, with 96 wells plates, Greiner 96 ﬂat-bottom
transparent polystyrol plates, was used for the determination
of CX concentrations in the studied samples.
3. Results andDiscussion
The polymeric microgels obtained in the process of SFDP
werepreparedusingknownmethodproposedandevaluated,
that is, by Pelton [23] as well as Saunders and Vincent
[24]. Consequent IR assessments conﬁrmed the reduction of
the double bonds in the monomer molecule [25], demon-
strating that the polymer was obtained [26]. The VPTT
was observed in the turbidity measurements, and, hence, all
the synthesized products were considered as thermosensitive
[27]. In the present research, we conﬁrmed the detailed
evaluations performed earlier—the VPTT for pNIPAM-A
and pNIPAM-B was around 34◦C, whereas, for pNIPAM-
C, it was observed at 32◦. The conductivity measurements
revealed complete puriﬁcation of obtained material from the
initiator or comonomer remains.
Both LM and SEM observations of freeze-dried mate-
rial revealed hydrogel-like structure in the case of CX-
pNIPAM-A compositions, whereas for CX-pNIPAM-B and
CX-pNIPAM-C compositions, we observed microspheres
of diameter between 0.5 and 5µm (Figures 1 and 2). As
it is evident from the LM microphotography, the spheres
tended to aggregate, however, in the observation ﬁeld, there
were no particles actually aggregated. The SEM photograph,
panel A (Figure 1), gives impression of some artifacts or
deposited CX on the surface of the ﬁber-like structures.
On the panel B of Figure 2, the obtained microgels have
some observable empty areas, between planar surfaces of
poly-N-isopropylacrylamide,verycharacteristicforthiskind
of material, possibly with some CX binded. This both
interesting issues, dealing with suspected speciﬁc CX depo-
sition on/in microgels, will be evaluated in next study. The
hydrophobized particles had rather smooth surface in the
SEM observations, with no observable artifacts, for example,
CX crystals.
The CX preparations, assessed in vitro at 22◦C, that
is, below the VPTT for the studied microgels, released an
initial burst of CX at diﬀerent time periods between 120
and 240min, followed by a period of ca. 24h, in which
the rate of release was approximately constant, approaching
the zero-order kinetics as it is depicted in Figure 3.T o
determine whether the release rate decreased exponentially,
the logarithms of the CX concentrations were plotted against
time, which produced straight lines, as shown in Figure 4.
The linear regression coeﬃcients given in Table 2 were over
0.9584, indicating an extremely close ﬁt of the values to
the line and supporting the premise that the release rate
decreased exponentially during the assay.
Depending on the preparations, the rates fell by approx-
imately up to 10 times in a period of 24h. During that
period,theconcentrationofCXattainedineachsamplelevel
of >20µg/mL, which is well above the minimal inhibitory
concentration (MIC) for most of the microbes (Figure 3).
The release rate was the highest in the case of aqueous
suspension of the CX base. The release rates for the polymers
beads were as follows: pNIPAM-C>pNIPAM-B>pNIPAM-
A>MC>PA. Furthermore, the prolongation of CX release
was ca. 30–50min. The release of CX in the presence of
pNIPAM can be divided into two stages (Table 3), and
the transition point for pNIPAM-A and pNIPAM-B was
observed at 90min, whereas, for pNIPAM-C, the apparent
release rate decreased signiﬁcantly after 130min.
Additionally, the ﬁrst-stage release rate for pNIPAM-
C was signiﬁcantly higher than those for pNIPAM-A and4 The Scientiﬁc World Journal
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Figure 1: Morphology of obtained polymers; the light microscopy images: (a) pNIPAM-A, (b) pNIPAM-B, (c) pNIPAM-C.
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Figure 2: Morphology of obtained polymers; the scanning electron microscopy images: (a) pNIPAM-A, (b) pNIPAM-B, (c) pNIPAM-C.
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Figure 3 :I n ﬂ u e n c eo ft h et y p eo fp o l y m e ri nt h ed o n o rc o m p a r t -
ment on the CX concentration in the acceptor medium at 22◦C.
The release from respective preparations was depicted: pNIPAM-
A-CX( ), pNIPAM-B-CX ( ), pNIPAM-C-CX ( ), MC-CX (◦),
PA-CX (×), and aqueous dispersion of CX (+), data from repeated
six experiments. The dashed straight line, parallel to the x-axis,
represents the MIC of CX for Staphylococcus mutans.
pNIPAM-B. Also, the release curves for pNIPAM-A and
pNIPAM-B did not show much diﬀerence in group. For
comparison, the respective data of the release rates for
M Ca n dP Aa r ep r e s e n t e di nTable 3, although the VPTT
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Figure 4: Inﬂuence of the type of polymer on the release kinetics
of CX from the polymeric bead at 22◦C. The release from respective
preparations was depicted as follows: pNIPAM-A-CX for ﬁrst stage
( ) and second stage (♦), pNIPAM-B-CX for ﬁrst stage ( )a n d
second stage ( ), pNIPAM-C-CX for ﬁrst stage ( ) and second
stage ( ), MC-CX (◦), PA-CX (×), and aqueous dispersion of CX
(+), data from repeated six experiments.
was not assessed for these polymers. For a speciﬁc time
period, the release of CX at temperature over VPTT was
diﬀerent than that at temperature below VPTT (Figure 5).The Scientiﬁc World Journal 5
Table 2: Linear regression coeﬃcients for the assessed release of CX
from the polymeric preparations, assuming ﬁrst-order process.
Release rates Release rates assessed at
22◦C( m i n −1)
Release rates assessed at
37◦C( m i n −1)
Preparation 1st stage 2nd stage 1st stage 2nd stage
pNIPAM-A-CX 0.9737 0.9864 0.9897 0.9675
pNIPAM-B-CX 0.9780 0.9783 0.9941 0.9967
pNIPAM-C-CX 0.9670 0.9584 0.9823 0.9960
MC-CX 0.9884 — 0.9838 —
PA-CX 0.8585 — 0.6922 —
H2O-CX 0.9949 — 0.9761 —
pNIPAM-A-CX, pNIPAM-B-CX, pNIPAM-C-CX: preparations of respec-
tive polymers detailed in the text with chlorhexidine, MC-CX: preparation
of methylcellulose and chlorhexidine, PA-CX: preparation of polyacrylic
acid and chlorhexidine, and H2O-CX: aqueous dispersion of chlorhexidine,
data from repeated six experiments.
0
20
40
60
80
C
o
n
c
e
n
t
r
a
t
i
o
n
(
µ
g
/
m
L
)
0 100 200 300 400 500
Time (min)
Figure 5 :I n ﬂ u e n c eo ft h et y p eo fp o l y m e ri nt h ed o n o rc o m p a r t -
ment on the CX concentration in the acceptor medium at 37◦C.
The release from respective preparations was depicted: pNIPAM-
A-CX( ), pNIPAM-B-CX ( ), pNIPAM-C-CX ( ), MC-CX (◦),
PA-CX (×), and aqueous dispersion of CX (+), data from repeated
six experiments. The dashed straight line, parallel to the x-axis,
represents the MIC of CX for Staphylococcus mutans.
The acquired concentrations exceeded the known mean
value of MIC of ca. 20µg/mL. Furthermore, the logarithms
of the CX concentrations were plotted against time, as
described earlier (Figure 6). The sequence of release rates
for the assessed polymers can be presented as follows:
MC>pNIPAM-C>pNIPAM-A>pNIPAM-B>PA. The highest
release rate was observed for the aqueous suspension of the
CX base. PA was the agent, which signiﬁcantly inﬂuenced the
release of CX. From the data presented in Table 3,i tc a nb e
observed that the concentration of CX released from the PA
preparation was extremely low.
To determine whether the synthesized polymers would
inﬂuence the release kinetics of CX, an in vitro model was
used,inwhichthesamplesofCXwithpolymerwereexposed
to a buﬀer under conditions recognized by the European
Pharmacopoeia and the United States Pharmacopoeia as
proper for the comparison of semisolid-drug forms applied
topically. It would be unlikely for the release rates of CX
and the concentrations observed in the acceptor ﬂuid to
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Figure 6: Inﬂuence of the type of polymer on the release kinetics
of CX from the polymeric bead at 37◦C. The release from respective
preparations was depicted as follows: pNIPAM-A-CX for ﬁrst stage
( ) and second stage (♦), pNIPAM-B-CX for ﬁrst stage ( )a n d
second stage ( ), pNIPAM-C-CX for ﬁrst stage ( ) and second
stage ( ), MC-CX (◦), PA-CX (×), and aqueous dispersion of CX
(+), data from repeated six experiments.
be in exact agreement with those on the skin surface,
where considerable variation in these parameters can be
expected with regard to the diﬀerences in the location of the
dermis, exposure to surface lipids, washing, and other eﬀects
observed on the skin surface. Nevertheless, the model system
demonstratedthatthecharacteristicsofthekineticsofrelease
diﬀer among the applied polymers. Release systems, like
those described in this study, in which a drug is dissolved or
dispersedinapolymervehicle,canbeclassiﬁedasdiﬀusional
matrix systems. They usually exhibit ﬁrst-order release
kinetics,inwhichtherateofreleasediminishesexponentially
with time, in response to the decreasing concentrations of
the drug in the polymeric matrix. However, the zero-order
release in numerous cases is considered to be the ideal system
for drug administration. That case is considered to occur
within a matrix system, when the drug is present in the core
of the matrix in a highly saturated state. Consequently, the
diﬀusion of the drug from the matrix is rate limiting [28].
The data from the kinetics experiment were also
employed for the evaluation of the maximum dose of CX
that might be absorbed over an 8h period by a patient
receiving a topical treatment. The received concentration in
the acceptor ﬂuid was up to 13mg/mL in the ﬁrst hour,
equivalent to a release of an estimated 1300mg of the drug
for the same period at a temperature over the VPTT, under
skinconditions.Thisisfarbelowthedailydoseof2000mgof
CX that humans are capable of ingesting without producing
any adverse eﬀects [29]. However, at temperature below
VPTT, the values were not higher than 10mg for pNIPAM-
B and pNIPAM-C and reached almost 20mg for pNIPAM-
A. In this case, the evaluated concentration of CX on the
skin reached the dose of 2000mg. Thus, the diﬀerences in
the release condition should be taken into account when
thermosensitiveparticlesareemployed,suchasdrugcarriers,
for the topical and dermal applications as well.
The eﬀective concentration of the drug on the skin
surface was also evaluated in terms of the time period6 The Scientiﬁc World Journal
Table 3: Release rates of CX from polymeric preparations.
Release rates assessed at 22◦C( m i n −1) Release rates assessed at 37◦C( m i n −1) Polymer
1st stage SD 2nd stage SD 1st stage SD 2nd stage SD
pNIPAM-A-CX 2.85 ×10
−3 0.01 ×10
−3 1.74 ×10
−3 0.02 ×10
−3 4.98 ×10
−3 0.02 ×10
−3 2.80 ×10
−3 0.26 × 10
−3
pNIPAM-B-CX 2.62 ×10
−3 0.02 ×10
−3 2.15 ×10
−3 0.05 ×10
−3 4.79 ×10
−3 0.04 ×10
−3 2.50 ×10
−3 0.18 × 10
−3
pNIPAM-C-CX 7.43 ×10
−3 0.04 ×10
−3 7.57 ×10
−4 0.40 ×10
−4 5.37 ×10
−3 0.04 ×10
−3 5.26 ×10
−3 0.39 × 10
−3
MC-CX 1.66 ×10
−3 0.03 ×10
−3 —— 1 .22 ×10
−2 0.01 ×10
−2 ——
PA-CX 3.60 ×10
−5 0.04 ×10
−5 —— 4 .09 ×10
−5 0.05 ×10
−5 ——
H2O-CX 3.29 ×10
−3 0.07 ×10
−3 —— 1 .06 ×10
−2 0.03 ×10
−2 ——
pNIPAM-A-CX, pNIPAM-B-CX, pNIPAM-C-CX: preparations of respective polymers detailed in the text with chlorhexidine, MC-CX: preparation of
methylcellulose and chlorhexidine, PA-CX: preparation of polyacrylic acid and chlorhexidine, and H2O-CX: aqueous dispersion of chlorhexidine, data from
repeated six experiments.
Table 4: Assessed eﬀective times∗.
Preparation Eﬀective time at the temperature
of 22◦C (min)
Eﬀective time at the temperature
of 37◦C (min)
The decrease of time at which the MIC is
acquired with the increase in the
temperature in the range of 15◦C (min)
pNIPAM-A-CX 130 80 50
pNIPAM-B-CX 145 80 65
pNIPAM-C-CX 60 90 −30
MC 210 70 140
CX 110 50 60
PA n/a n/a n/a
∗Eﬀective time was recognized as the period from the start of the release to the moment when MIC for CX was observed, n/a: not assessed.
after which the concentration of MIC could be acquired. In
general, the presence of polymers resulted in the decrease
of release rate, with the extreme case of PA. When the
temperature increased, the MIC in the acceptor ﬂuid was
observed in advance, and the MC preparation was the most
signiﬁcantcase.Ontheotherhand,theincreaseintherelease
rate and the corresponding decrease in the eﬀective time
can be elucidated in terms of the decrease in viscosity with
respect to the increase in temperature. Nevertheless, in the
presence of pNIPAM-C microgel, the eﬀective time, that is,
the duration since the start of the release to the moment
when the MIC is reached, in thermal conditions over the
VPTT,increasedfrom60to90min.ThepNIPAM-Cpolymer
was characterized as a hydrophobized macromolecule, with
butyl acrylate functional group—thus, the release prolon-
gation could be attributed to some interactions between
the insoluble CX molecule and the hydrophobic functional
groups of the polymer. The assessed eﬀective times are
presented in Table 4.
The MIC of CX for Streptococcus specia, one of the
main pathogens in the respiratory tract, is in the range of
0.25–64µg/mL, that is, 0.25–64mg/L [30–32]. The proposed
polymer systems for the release of active substance enable
the achievement of direct bactericidal and bacteriostatic
levels of CX in the application area after ca. 60–130min,
in the case of pNIPAM polymers at temperature below
the VPTT. However, when the temperature is over the
VPTT value for the assessed synthesized polymers, the
antibacterial eﬀect is observed at 80–90min. The release
of the CX from the polymeric preparations is observed to
intensifysimultaneouslywiththeincreaseinthetemperature
during the release process. However, the only exception was
pNIPAM-C. In the presence of this polymer, the eﬀective
time, that is, time needed to observe the MIC in the
acceptor compartment, increased at the temperature over
the VPTT. This can be owing to the eﬀective embedding
of the CX in the microsphere structure—one of the factors
may be the lipophilic interaction of the polymer tertiary-
butyl chains with the CX molecules. The future development
of the N-isopropyl acrylamide microgels as drug carriers
is supported by reported cytocompatibility of the pNIPAM
nanoparticles [33]. The obtained data may be valuable for
the development of new drug forms for controlled delivery
of active substances onto the skin at diﬀerent environmental
temperatures, where the skin surface temperature could
vary in the range from 14◦Cu pt o4 2 ◦C. Therefore, the
therapeutic activity of the locally applied drug depends on
both the thermodynamic activity of the active molecule
compound and the pharmaceutical system, which enables
the release of the molecule, as well as on the vasoconstrictive
activity of the skin blood vessels. However, the release of
the drug might be diﬀerent when a patient is suﬀering from
fever,whencomparedwiththehealthysubject.Furthermore,
cryotherapy might also inﬂuence the release of the drug
applied onto the skin.
4. Conclusions
The preparations evaluated in this study could be employed
as CX carriers to achieve eﬀective drug concentrations atThe Scientiﬁc World Journal 7
diﬀerent skin surface temperatures. The proposed polymer
systems for the release of active substance enable the
achievement of direct bactericidal and bacteriostatic levels
of CX in the application area after ca. 60–130min, in the
case of pNIPAM polymers at temperature below the VPTT.
The antibacterial eﬀect is observed at 80–90min when the
temperature is over the VPTT value. Also, the data obtained
for the in vitro preliminary selection of the thermosensitive
polymers could be used for the further in vivo assays. This
class of thermosensitive polymers can be further developed
to achieve controlled release of the drug at diﬀerent thermal
conditions of the body.
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